We identified eligibility in two scenarios based on the pre-screening protocol and actual patient laboratory values from the MAESTRO-NASH trial
In a study targeting suicide attempts as the endpoint, a control group with a higher prevalence of depression and suicidal ideation might lead to outcome bias, as evidenced by the increased incidence of suicidal ideation within the control group
Absolute contraindications Medullary thyroid cancer MEN-2 Pregnancy or breastfeeding Prior severe allergic reaction to GLP-1 medications Conditions requiring extra caution Gastroparesis or delayed gastric emptying History of pancreatitis Advanced diabetic retinopathy Use alongside medications that increase hypoglycemia risk These and a few other situations require individualized assessment, which is why specialty endocrine care matters
Conclusion: Our research presents compelling evidence of epigenetic alterations in complement genes associated with MASLD
The biggest concern is that you could potentially get a product that has something harmful in it, but that is unlikely to happen
The study, which was published in JAMA OtolaryngologyHead & Neck Surgery , makes a case for paying close attention to how well you can smell and taste after using one of these medications